Proxy Votes Now

Home › Funds › Davis Balanced Fund

Davis Balanced Fund (DCSCX) proxy voting record 2025-2026

Fund family: DAVIS SERIES INC · Filed by DAVIS SERIES INC (CIK 203002) · SEC series S000003446

Share classes and tickers: DCSCX (C000009545), DCSYX (C000009546), RPFCX (C000009543)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 484 with, 43 against, 0 abstentions (not counted as with management); 4 items carried no recommendation. Shareholder proposals: 7 FOR, 40 AGAINST, 0 abstained, by the filing’s own vote-source field.

No item-level comparison with other DAVIS SERIES INC funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 72.1% of this fund’s 527 such votes could be given a sector; the other 147 (27.9%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance153149.2%
Health Care7733.9%
Technology701622.9%
Industrials3013.3%
Consumer Discretionary17423.5%
Consumer Staples1715.9%
Energy1600.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3290
Corporate Governance5817
Audit-related340
Capital Structure300
Compensation262
Say-on-Pay250
Environment or Climate1010
Other Social Issues99
Extraordinary Transactions60
Human Rights or Human Capital/workforce44

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Viatris Inc.December 5, 2025$23M150
Viatris Inc.May 15, 2026$22M150
Berkshire Hathaway Inc.May 2, 2026$21M161
Quest Diagnostics IncorporatedMay 20, 2026$19M141
Applied Materials, Inc.March 12, 2026$17M120
CVS Health CorporationMay 14, 2026$16M171
Capital One Financial CorporationMay 8, 2026$15M161
Amazon.com, Inc.May 20, 2026$11M174

Notable votes against management

MeetingCompanyProposalFundMgmt
May 2, 2026Berkshire Hathaway Inc.Shareholder proposal requesting that the Company issue a report disclosing the Board's oversight framework for workforce and human-capital management across its operating subsidiaries. Shareholder proposalAgainstFor
May 20, 2026Quest Diagnostics IncorporatedStockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 14, 2026CVS Health CorporationStockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposalAgainstFor
May 8, 2026Capital One Financial CorporationStockholder proposal to require a shareholder vote on golden parachute arrangements. Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposalAgainstFor
April 16, 2026Texas Instruments IncorporatedStockholder proposal to permit stockholders to act by written consent. Shareholder proposalAgainstFor
April 22, 2026The Cigna GroupShareholder Proposal - Shareholder Right to Act by Written Consent Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding report on Al data usage oversight. Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst
May 20, 2026Markel Group Inc.Shareholder proposal for a report on the Company's strategies and action plans to mitigate material environmental risks. Shareholder proposalAgainstFor
May 20, 2026Markel Group Inc.Shareholder proposal to give shareholders an ability to call for a special shareholder meeting. Shareholder proposalAgainstFor

Search this fund’s votes by company

532 ballot items at 33 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Davis Balanced Fund (DCSCX) voted at 33 shareholder meetings of 32 companies, on 532 ballot items in all. Where management made a recommendation, the fund followed it on 91.8% of the items and voted against it 43 times. Its most frequent area of disagreement was corporate governance (17 of its votes against management). It voted on 47 shareholder proposals.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.